Skip to content

OTC FOCUS: what changed

BE 0867.755.466NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2023 and 2024

Net result for the year
€108
2023 · €60+€48
Equity
€20,186
2023 · €20,078+€108
Cash
-
not filed
Balance sheet total
€27,302
2023 · €27,152+€149

Largest movements

2023 to 2024
Assets

No asset line moved by more than 1% of the balance sheet total.

    Equity and liabilities

    No liability line moved by more than 1% of the balance sheet total.

      Income statement
      • Gross operating margin +€353

        up €353 (+44.0%), from -€802 to -€449

      • Financial income -€191

        down €191 (-10.8%), from €1,767 to €1,576

      • Financial charges +€88

        up €88 (+9.8%), from €890 to €978

      • Taxes +€27

        up €27 (+188%), from €14 to €41

      Change in the result, 2023 to 2024

      effect on the result

      For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

      Result 2023 €60
      Gross operating margin +€353
      Financial income -€191
      Financial charges -€88
      Taxes -€27
      Result 2024 €108
      raises the resultlowers the result

      Derived cash bridge

      cash 2023 to 2024

      Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.

      Every line side by side 33 lines
      Line Code 2023 2024 Change %
      Total assets 20/58 €27,152 €27,302 +€149 +0.5%
      Fixed assets 21/28 €124 €124 = 0.0%
      Financial fixed assets 28 €124 €124 = 0.0%
      Current assets 29/58 €27,028 €27,177 +€149 +0.6%
      Amounts receivable within one year 40/41 €27,028 €27,177 +€149 +0.6%
      Trade receivables 40 €1,235 €1,235 = 0.0%
      Other amounts receivable 41 €25,793 €25,942 +€149 +0.6%
      Total equity and liabilities 10/49 €27,152 €27,302 +€149 +0.5%
      Equity 10/15 €20,078 €20,186 +€108 +0.5%
      Contributions 10/11 €12,500 €12,500 = 0.0%
      Reserves 13 €1,860 €1,860 = 0.0%
      Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
      Other 1319 €1,860 €1,860 = 0.0%
      Profit (loss) carried forward 14 €5,718 €5,826 +€108 +1.9%
      Amounts payable 17/49 €7,074 €7,115 +€41 +0.6%
      Amounts payable within one year 42/48 €7,074 €7,115 +€41 +0.6%
      Financial debts 43 €4,774 €4,774 +€0 0.0%
      Credit institutions 430/8 €4,774 €4,774 +€0 0.0%
      Trade debts 44 €2,263 €2,263 = 0.0%
      Suppliers 440/4 €2,263 €2,263 = 0.0%
      Taxes, remuneration and social security 45 €14 €55 +€41 +288%
      Taxes 450/3 €14 €55 +€41 +288%
      Other amounts payable 47/48 €23 €23 = 0.0%
      Gross operating margin 9900 -€802 -€449 +€353 +44.0%
      Operating profit (loss) 9901 -€802 -€449 +€353 +44.0%
      Financial income 75/76B €1,767 €1,576 -€191 -10.8%
      Recurring financial income 75 €1,767 €1,576 -€191 -10.8%
      Financial charges 65/66B €890 €978 +€88 +9.8%
      Recurring financial charges 65 €890 €978 +€88 +9.8%
      Profit (loss) for the period before taxes 9903 €74 €149 +€74 +99.9%
      Income taxes 67/77 €14 €41 +€27 +188%
      Profit (loss) for the period 9904 €60 €108 +€48 +79.2%
      Profit (loss) for the period to be appropriated 9905 €60 €108 +€48 +79.2%

      Value

      latest balance sheet 31-12-2024 · indication, not a valuation or advice

      Indicative value of the equity

      Indication, not a valuation or advice
      €10,268 to €10,338

      Midpoint €10,297 · 50% capitalised earnings, 50% adjusted equity

      Capitalisation rate 12% result over 3 years earnings weight 50%

      Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

      Adjusted equity €20,186
      Capitalised earnings €350 to €490
      Indication €10,268 to €10,338

      Adjusted equity

      balance sheet 31-12-2024
      Equity (10/15)
      €20,186
      Revaluation of assets
      €0
      Deferred tax on the revaluation
      €0
      Other adjustment
      €0
      Adjusted equity
      €20,186

      Capitalised earnings

      net result for the year (9904)
      2024
      €108
      2023
      €60
      2022
      -€22
      2021
      €269
      2020
      €609
      Average result
      €49
      Divided by the capitalisation rate
      14% / 12% / 10%
      Capitalised earnings
      €350 / €408 / €490

      Limits of the indication

      • Checked holds no market prices or comparable transactions.
      • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
      • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
      • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
      • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

      For a valuation to base a decision on, go to a company auditor or a certified accountant.

      Calculation and sources

      Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.